An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)
NCT01200225
·
clinicaltrials.gov ↗
COMPLETED
Status
1155
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C, Chronic
Sponsor
Hoffmann-La Roche